Yuh-Min ChenProf. Dr

Name: Yuh-Min Chen Nationality: Taiwan, ROC Medical School 1978-1985 National Yang-Ming Medical College 1983-1985 Intern, Taipei Veterans General Hospital Postgraduate Training 1987-1989 Resident, Medical Department, Uan-Chyan Veterans Hospital, Taiwan 1989-1992 Resident, Chest Department, Taipei Veterans General Hospital 1992-1993 Chief Resident, Chest Department, Taipei Veterans General Hospital 1993-1994 Fellow, Chest Department, Taipei Veterans General Hospital 1993-1995 Fellow, Cancer Clinical Research Center, Institute of Biomedical Sciences, Academic Sinica 1996-1997 Visiting fellow, National Cancer Institute, National Institutes of Health, USA 1994-1998 Ph.D., Institute of Clinical Medicine, National Yang-Ming University Academic Appointment 1991-present Board certified, Internal Medicine 1992-1997 Clinical Lecturer, Medical Department, National Yang-Ming University 11993- present Board certified, Chest Medicine 1994-2026 Attending physician, Department of Chest Medicine, Taipei VGH 1995- present Board certified, Medical Oncology 1997-1999 Clinical Assistant Professor, School of Medicine, National Yang-Ming University 2004-2012 Clinical Associate Professor, School of Medicine, National Defense University 1998-2008 Adjunct attending physician, Institute of Cancer Research, National Health Research Institutes 1999-2002 Assistant Professor, School of Medicine, National Yang-Ming University 2002-2013 Associate Professor, School of Medicine, National Yang-Ming University 2008/8-2013 Clinical Professor, Taipei Medical University 2013-2022 Professor, College of Medical Science and Technology, Taipei Medical University 2015/9/1-2020/1/15 Chief, Division of General Chest Medicine, Department of Chest Medicine, Taipei Veterans General Hospital, Tapei 2016-2026 Chairman, Thoracic Oncology Multidisciplinary Team, Taipei Veterans General Hospital, Taipei 2016/2/1-present Professor, School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 2020/01/16-2026/01/15 Head, Department of Chest Medicine, Taipei Veterans General Hospital, Taipei 2026/3/2- Head, Clinical Research Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei Professional Interests and Specialties 1. Internal Medicine 2. Pulmonary and Critical Care Medicine 3. Medical Oncology, especially Thoracic Oncology 4. Cell Biology and Molecular Biology 5. Tumor Immunology 6. Chemotherapy 7. Targeted Therapy 8. Immunotherapy Professional Societies Member, European Society of Clinical Oncology Member, American Society of Clinical Oncology Member, International Association for The Study of Lung Cancer Member, Asia-Pacific Society of Respirology Research Committee 2020 – present Fellow, American College of Chest Physicians Member, Society of Internal Medicine (Taiwan) Member, Society of Ultrasound in Medicine (ROC) Member, Taiwan Clinical Oncology Society Member, Taiwan Cancer Society Member, Taiwan Society of Respiratory and Intensive Care Medicine Member, Chinese Medical Association (Taipei) Member, Taiwan Lung Cancer Society Member, Asia-Pacific Society of Respirology Member, European Respiratory Society Secretary, Taiwan Clinical Oncology Society 1994-2001 Secretary General, Taiwan Lung Cancer Society 2000-2008, 2009-2012 Secretary General, Taiwan Clinical Oncology Society 2001-2007 Secretary General, 15th Taiwan Jointed Cancer Conference, May 2018, Taipei, Taiwan President, Taiwan Clinical Oncology Society 2007-2013 Audit, Taiwan Society of Palliative Medicine 2008-2010 Director, Chinese Oncology Society 2011-2013 Director, Taiwan Clinical Oncology Society 2013-present Member of Scientific Committee, 12th, 13th, and 14th World Conference on Lung Cancer, IASLC 2007, 2009, 2011 Section Chair of 13th and 14th World Conference on Lung Cancer, IASLC, 2009 and 2011 Co-Chair of Organiging Committee, Taiwan Joint Cancer Conference 2000-2013, 2016, 2017, 2019, 2020 Chair of Organizinng Committee of Annual Meeting of Cross-Strait Academic Conference on Oncology 2007-2014 Vice-Chair of Organizing Committee of bi-annual meeting of Chinese Anti-Cancer Society 2007-2013 Organizing Committee of Round Asia Oncology Forum (RAOF) 2012, Taipei, Taiwan 2012/8/31-20212/9/2 Committee member of Avastin global advisory board meeting in 15th World Conference on Lung Cancer (WCLC 2013), Sydney, Australia, October 31, 2013 Chair of Iressa Asia area advisory board meeting in Taipei, Taiwan, March 8, 2014. President, Taiwan Lung Cancer Society 2015/May/8 – 2021/August/26 Chair, TLCS and IASLC Lung Cancer Symposium, October 28-29, 2017, Taipei, Taiwan Chair, 23th Taiwan Jointed Cancer Conference, May 5-6, 2018, Taipei, Taiwan Committee member of 2nd Expanded Asis NSCLC Adboard Meeting for Afatinib, Taipei, Taiwan, October 6th, 2018 Chair, 2020 Taiwan Lung Cancer Society International Symposium on Treatment Advances in Lung Cancer, Taipei, January 1-12, 2020 Councillor, Asia-Pacific Society of Respirology 2024/Aug - prrsent President, The 9th Asia-Pacific region conference of the International Union Against Tuberculosis and Lung Disease and the 2024 Summer Meeting of the Taiwan Society of Pulmonary and Critical Care Medicine, 2024/4/26-2024/4/29 Taipei, Taiwan President, The 10th Asian Pacific Congress on Bronchology and Interventional Pulmonology and the 2025 Summer Meeting of the Taiwan Society of Pulmonary and Critical Care Medicine, 2025/6/20-2025/6/22 Taipei, Taiwan President, Taiwan Society o Pulmonary and Critical Care Medicine 2023/Decemebr/14th – present Secretary General, Asian Pacific Society of Respirology 2025 Dec- Bibliography A. Referred Paper (*first author or corresponding author, ‡SCI paper) ‡ 1. Tzu-Yu Chen, Li-Hsin Chien, Shih Sheng Jiang, Jiyeon Choi, Hsiao-Han Hung, Chin-Fu Hsiao, Jianxin Shi, Batel Blechter, Charles E. Breeze, Gee-Chen Chang, Kuan-Yu Chen, Ying-Huang Tsai, Wu-Chou Su, Ming-Shyan Huang, Yuh-Min Chen, Yueh-Feng Wen, Chung-Yu Chen, Chih-Liang Wang, Fang-Yu Tsai, Hui-Ling Chen, Wan-Shan Hsieh, Hsien-Chih Lin, Lu-Hai Wang, Chien-Jen Chen, Pan-Chyr Yang, Chih-Yi Chen, Nathaniel Rothman, Stephen J. Chanock, Qing Lan, I-Shou Chang, Chao A. Hsiung. Identifying expression and DNA methylation biomarkers for lung adenocarcinoma risk in East Asia. J National Cancer Institute 2026 accepted. ‡ 2. James Chih-Hsin Yang, Yuh-Min Chen, Ullas Batra, Kien Hung Do, Piyada Sitthideatphaiboon, Pongwut Danchaivijitr, KangYun Lee, Jarin Chindaprasirt, Cheng-Ta Yang, GeeChen Chang, Chaiyut Charoentum, Teerapat Ungtrakul, Juan Ignacio Hernandez Moran, Ryan Hartmaier, Ike Igwegbe, Alexander Gont, Matthew Haskins, Wanning Xu, Jonathan W. Riess.nSavolitinib Plus Osimertinib in Epidermal Growth Factor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase 2 trial. Clinical Lung Cancer 2025; 27: 38-46. ‡ 3. Chia-Ju Wu, Susan Shin-Jung Lee, Chin-Chung Shu, Shu-Min Lin, Chang- Ching Lee, Jhong-Ru Huang, Tsai-Yu Wang, Sheng-Wei Pan, Jia-Yih Feng, Yuh-Min Chen. Prevalent and incident latent tuberculosis infetion among healthcare workers in Taiwan: A multi-center observational study. Journal of Microbiology, Immunology and Infection 2025 online 20 November. ‡ 4. Batel Blechter, Xiaoyu Wang, Juncheng Dai, Christiana Karsonaki, Jianxin Shi, ………Yuh-Min Chen,…. Takashi Kohno, Qing Lan, Haoyu Zhang. Stratifying Lung Adenocarcinoma Risk with Multi-ancestry Polygenic Risk Scores in East Asian Never-Smokers. Journal of National Cancer Institute 2025; October. https://doi.org/10.1093/jnci/djaf272. ‡ 5. Sheng-Wei Pan, Chin-Chung Shu, Jia-Yih Feng, Lawrence Shih-Hsin Wu, Pin Huai Wang, Yung-Che Chen, Jann-Yuan Wang, Hao-Chien Wang, Wei-Juin Su, Yuh-Min Chen, Chong-Jen Yu. Association of T-cell immunoglobulin and mucin domain-3 gene (TIM3) polymorphism with susceptibility and severity of Mycobacterium avium complex lung disease: a prospective study in Taiwan. International Journal of Infectious Diseases 2025 Oct: 159: 108025. doi: 10.1016/j.ijid.2025.108025.. ‡ 6. Thi Thanh Nha Nguyen; Pei-Yu Chen; Ming-Yi Zheng; Ting-Kuang Lin; Yuh-Min Chen; Shih-Hwa Chiou, Yu-Ting Chou. Intrinsic PDL1 Signaling Modulates TGFBI-Mediated Growth Suppression in Lung Adenocarcinoma. Cancer Science 2025 Oct;116(10):2737-2749. doi: 10.1111/cas.70150. ‡ 7. Ying-Hsuan Hwang, Chien-Yeh Chi, Chih-Teng Chiang, Yuh-Min Chen, I-Hsuan Hwang, Chun-Feng Huang, Yu-Chun Chen, Shinn-Jang Hwang. Bibliographic analysis of Taiwanese respiratory system publications: An analysis of Web of Science database from 1972 to 2023. J Chinese Medical Association 2025; 88(9): 709-16. ‡ 8. Che-min Hsu, Chia-Ju Wu, Chih-Jung Chang, Sheng-Wei Pan, Yen-Han Tseng, Jhong-Ru Huang, Wei-Juin Su, Jia-Yih Feng, Yuh-Min Chen. Recurrence of Tuberculosis and Associated Risk Factors Among Non-HIV Patients in Taiwan: A Retrospective Cohort Study. Journal of Infection and Public Health 18 (2025) 102912 ‡ 9. Hsu-Ching Huang, Han-Jhih Chang, Chi-Lu Chiang, Hsin-Yi Huang, Yung-Hung Luo, Yuh-Min Chen, Tsu-Hui Shiao, Chao-Hua Chiu. A Prospective Exploratory Study of Functional Immunity Assessed by Pre-Treatment IGRA in Relation to Different Systemic Therapies in Patients with Advanced-stage NSCLC. J Thorac Oncol Clinical & Research Reports 2025 May 09 accepted. ‡ 10. Sheau-Ning Yang, Chuan-Yen Sun, Kun-Ta, Chou, Diahn-Warng Perng, Kang-Cheng Su, Yi-Han Hsiao, Hsin-Kuo Ko, Yuh-Min Chen. Impact of Small Airway Dysfunction on Asthma Presentation and Future Exacerbation Risk: A Cohort Study. Annals of Medicine 2025 in print. 11. Oishi Banerjee, Agustina Saenz, Kay Wu, Warren Clements, Adil Zia, Dominic Buensalido, Helen Kavnoudias, Alain S. Abi-Ghanem, Nour El Ghawi, Cibele Luna, Patricia Castillo, Khaled Al-Surimi, Rayyan A. Daghistani, Yuh-Min Chen, Heng-sheng Chao, Lars Heiliger, Moon Kim, Johannes Haubold, Frederic Jonske, Pranav Rajpurkar. ReXamine-Global: A Framework for Uncovering Inconsistencies in Radiology Report Generation Metrics. arXiv:2408.16208. (2024) ‡ 12. Jia-Yih Feng, Sheng-Wei Pan, Yen-Han Tseng, Chih-Jung Chang, Wei-Juin Su, Yuh-Min Chen. Reduced host cell-free DNA as a biomarker in latent tuberculosis infection among tuberculosis contacts. Tuberculosis 2025 in print.   ‡ 13. Ting Wei Wang, Chih-Keng Wang, Jia-Sheng Hong, Heng-Sheng Chao, Yuh-Min Chen, Yu-Te Wu. Deep Learning in Thoracic Oncology: Meta-Analytical Insights into Lung Nodule Early Detection Technologies. Cancers 2025; 17 (4), 621 ( https://doi.org/10.3390/cancers17040621). ‡ 14. Enriqueta Felip, Nasser Altorki, Caicun Zhou, Eric Vallières, Tibor Csoszi, Ihor O. Vynnychenko, Oleksandr Goloborodko, Achim Rittmeyer, Martin Reck, Alex Martinez-Marti, Hirotsugu Kenmotsu, Yuh-Min Chen, Antonio Chella, Shunichi Sugawara, Chenqi Fu, Marcus Ballinger, Yu Deng, Minu K. Srivastava, Elizabeth Bennett, Barbara J. Gitlitz, Heather A. Wakelee, on behalf of the IMpower010 study investigators. Five-year survival outcomes with atezolizumab after chemotherapy in resected stage IB-IIIA non-small cell lung cancer (IMpower010): an open-label, randomized, phase 3 trial. J Clinical Oncology 2025 accepted. ‡ 15. Ruei-Lin Sun, Pei-Ya Liao, Ying-Ting Liao, Yi-Chen Yeh, Chi-Lu Chiang, Yuh-Min Chen, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Hsu-Ching Huang, Chia-I Shen, Yen-Han Tseng, Yen-Hsiang Huang, Yung-Hung Luo, Tsung-Ying Yang. Real-world therapeutic strategies and survival outcomes in advanced HER2-mutant non-small cell lung cancer. J Chinese Medical Association 2025; 88(4): 307-315. ‡ 16. Yen-Han Tseng, Trieu Thi My Tran, Jinghua Tsai Chang, Yu-Tang Huang, Anh Thuc Nguyen, Ian Yi-Feng Chang, Yi-Tung Chen, Hao-Wen Hsieh, Yue-Li Juang, Peter Mu-Hsin Chang, Tzu-Yi Huang, Ying-Chih Chang, Yuh-Min Chen, Hsuan Liu, Chi-Ying F Huang. Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer. Cell Death Discovery 2025;11(1): 26. doi: 10.1038/s41420-025-02300-7. ‡ 17. Batel Blechter, Chao Agnes Hsiung,….. Yuh-Min Chen, …Takashi Kohno, Qing Lan. Polygenic risk score and lung adenocarcinoma risk among never-smokers by EGFR mutation status-a brief report. Journal of Thoracic Oncology 2024; 20(4): 521-530. ‡ 18. Fang-Chi Lin, Hao-Min Cheng, Ming Ling Yih, Kun-Ta Chou, Yuh-Min Chen, Hwa‑Yen Chiu. The Relationship between Blood Pressure and the Severity of Obstructive Sleep Apnea – A Retrospective Study. Hypertension Research 2025; 48 (January): 1379-1388. (IF 2024: 4.3) ‡ 19. Ting-Wei Wang, Jia-Sheng Hong, Hwa-Yen Chiu, Heng-Sheng Chao, Yuh-Min Chen, Yu-Te Wu. Standalone deep learning versus experts for diagnosis lung cancer on chest computed tomography: a systematic review. European Radiology 2024; 34:397–7407. (IF 2024: 4.7) ‡ 20. Ping-Hsing Tsai, Jun-Ren Sun, Yueh Chien, Man Sheung Chan, Winnie Khor, Hsin-Chou Yang, Chih-Heng Huang, Chia-Ni Hsiung, Teh-Yang Hwa, Yi-Ying Lin, Chih-Ling Yeh, Mong-Lien Wang, Yi-Ping Yang, Yuh-Min Chen, Fu-Ting Tsai, Meng-Shiue Lee, Yun-Hsiang Cheng, Shan-Ko Tsai, Ping-Cheng Liu, Shih-Jie Chou, Shih-Hwa Chiou. Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids. Journal of Advanced Research 2024; 60: 127–140. (IF 2024: 11.4) ‡ 21. Ting-Wei Wang, Heng-Sheng Chao, Hwa-Yen Chiu, Chia-Feng Lu, Chien-Yi Liao, Yen Lee, Jyun-Ru Chen, Tsu-Hui Shiao, Yuh-Min Chen, Yu-Te Wu. Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors. Translational Oncology 2024; 39 (Jan): 101826. (IF 2024: 4.5) ‡ 22. Chih-Jung Chang, Jhong-Ru Huang, Yen-Han Tseng, Sheng-Wei Pan, Jia-Yih Feng, Wei-Juin Su, Yuh-Min Chen. Global cell-free DNA methylation in patients with active tuberculosis and tuberculosis contacts with latent tuberculosis infection. Diagnostic Microbiology & Infectious Disease 2025; 111: 116559. (IF 2024: 2.1) ‡ 23. Chih-Jung Chang, Jhong-Ru Huang, Hisao-Chin Shen, Chuan-Yen Sun, Ying-Ting Liao, Hung-Jui Ko, Yuh-Min Chen, Wei-Chih Chen, Jia-Yih Feng, Kuang-Yao Yang. Characteristics and utcomes of ICU-admitted COVOD-19 patients in the Omicron and Alpha-dominated periods. Journal of the Formosan Medical Association. 2025 in print. ‡ 24. Po-Chun Lo, Jia Yih Feng, Yi-Han Hsiao, Kang-Cheng Su, Kun-Ta Chou, Yuh-Min Chen, Hsin-Kuo Ko, Diahn-Warng Perng. Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction. Respiratory Research 2024; 25: 209. ‡ 25. Hsiao-Chin Shen, Jhong-Ru Huang, Chuan-Yen Sun, Ying-Ting Liao, Hung-Jui Ko, Chih-Jung Chang, Jia-Yih Feng, Yuh-Min Chen, Wei-Chih Chen, Kuang-Yao Yang. Influence of vaccination on critical COVID-19 patients with acute respiratory failure: a retrospective cohort study. European Journal of Medical Research 2024; 29: 243. *‡ 26. Yung-Hung Luo, Chia-I Shen, Chi-Lu Chiang, Yuh-Min Chen. Immune Signatures of Patients with Advanced Non–Small-Cell Lung Cancer for Efficacy Prediction After Immunotherapy. Therapeutic Advances in Medical Oncology 2024; 16: 1-18. (IF 4.3) ‡ 27. Terufumi Kato, James Chih-Hsin Yang, Myung-Ju Ahn, Hiroshi Sakai, Masahiro Morise, Yuh-Min Chen, Ji-Youn Han, Jin-Ji Yang, Jun Zhao, Te-Chun Hsia, Karin Berghoff, Rolf Bruns, Helene Vioix, Simone Lang, Andreas Johne, Xiuning Le, Paul K. Paik. Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION. British Journal of Cancer 2024; 130(10):1679-1686. *‡ 28. Hwa-Yen Chiu, Ting-Wei Wang, Ming-Sheng Hsu, Heng-Shen Chao, Chien-Yi Liao, Chia-Feng Lu, Yu-Te Wu, Yuh-Min Chen. Progress in Serial Imaging for Prognostic Stratification of Lung Cancer Patients Receiving Immunotherapy: A Systematic review and Meta-Analysis. Cancers 2024, 16, 615. https://doi.org/10.3390/cancers16030615 ‡ 29. Ying-Ting Liao, Hsiao-Chin Shen, Jhong-Ru Huang, Chuan-Yen Sun, Hung-Jui Ko, Chih-Jung Chang, Yuh-Min Chen, Jia-Yih Feng, Wei-Chih Chen, Kuang-Yao Yang. Clinical characteristics and outcomes among critically ill patients with cancer and COVID-19-related acute respiratory failure. BMC Pulm Med 2024 Jan 15; 24(1): 34. doi: 10.1186/s12890-024-02850-z. ‡ 30. Gee-Chen Chang, Chao-Hua Chiu, Chong-Jen Yu, Yeun-Chung Chang, Kuo-Hsuan Hsu, Yu-Chung Wu, Chih-Yi Chen, Hsian-He Hsu, Ming-Ting Wu, Cheng-Ta Yang, Inn-Wen Chong, Yu-Ching Lin, Te-Chun Hsia, Meng-Chih Lin, Wu-Chou Su, Chih-Bin Lin, Kang-Yun Lee, Yu-Feng Wei, Gong-Yau Lan, Wing-P Chan, Kao-Lun Wang, Mei-Han Wu, Hao-Hung Tsai, Chih-Feng Chian, Ruay-Sheng Lai, Jin-Yuan Shih, Chi-Liang Wang, Jui-Sheng Hsu, Kun-Chieh Chen, Chun-Ku Chen, Jiun-Yi Hsia, Chung-Kan Peng, En-Kuei Tang, Chia-Lin Hsu, Teh-Ying Chou, Wei-Chih Shen, Ying-Huang Tsai, Chun-Ming Tsai, Yuh-Min Chen, Yu-Chin Lee, Chien-Jen Chen, Yung-Liang Wan, Chao Agnes Hsiung, Pan-Chyr Yang, and TALENT Investigators. Low-Dose CT Screening of Lung Cancer in Never Smokers at High Risk - The TALENT Study. Lancet Respiratory Medicine 2024 Feb;12(2):141-152. *‡ 31. Chi-Lu Chiang, Hsu-Ching Huang, Yung-Hung Luo, Chia-I Shen, Heng-Sheng Chao, Yen-Han Tseng, Teh-Ying Chou, David S. Schrump, Yi-Chen Yeh, Yuh-Min Chen. Clinical Utility of Immunohistochemical Subtyping in Patients with Small Cell Lung Cancer. Lung Cancer 2024 Feb:188:107473. doi: 10.1016/j.lungcan.2024.107473. *‡ 32. Gee-Chen Chang, Jin-Yuan Shih, Chong-Jen Yu, Heng-Sheng Chao, Cheng-Ta Yang, Chien-Chung Lin, Jen-Yu Hung, Sheng-Yen Hsiao, Chin-Chou Wang, Chih-Feng Chian, Te-Chun Hsia, Yuh-Min Chen. Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer. PLOS One 2024;19(5): e0303046. *‡ 33. Yen-Han Tseng, Ching-Liang Ho, Chih-Feng Chian, Chi-Lu Chiang, Heng-sheng Chao, Chao-Hua Chiu, Chen-Liang Tsai, Wann-Cherng Perng, Chun-Fu Hsiao, Mei-Hsing Chuang, Kai-Hsiung Ko, Yuh-Min Chen. A study to evaluate the safety and efficacy of ex vivo expanded autologous immune killer cells in stage IV non-small cell lung cancer patients previously treated at least 2 lines of chemotherapy with/without target therapy. Scientific Reports 2024; 14: 19374. *‡ 34. Yung-Hung Luo, Chia-I Shen, Chi-Lu Chiang, Hsu-Ching Huang, Yuh-Min Chen. Dynamic Immune Signatures of Patients with Advanced Non–Small-Cell Lung Cancer for Infection Prediction After Immunotherapy. Frontiers in Immunology 2024; 15: Jan 26: https ://doi.org/10.3389/fimmu.2024.1269253. ‡ 35. Hsiao-Chin Shen, Jia-Yih Feng, Chuan-Yen Sun, Jhong-Ru Huang, Yuh-Min Chen, Wei-Chih Chen, Kuang-Yao Yang. Analysis of the effect of cytomegalovirus infection in clinical outcomes and prolonged duration of SARS-CoV-2 shedding in intensive care unit patients with COVID-19 pneumonia. Ther Adv Respir Dis 2023 Jan-Dec:17:17534666231209150. doi: 10.1177/17534666231209150. ‡ 36. Chi-Lu Chiang, Huai-Che Yang, Ying-Ting Liao, Yung-Hung Luo, Yuan-Hung Wu, Hsiu-Mei Wu, Yuh-Min Chen. Treatment and Survival of Patients with Small Cell Lung Cancer and Brain Metastasis. Journalof Neuro-Oncology 2023 Nov;165(2): 343-351. *‡ 37. Chia-Feng Lu, Chien-Yi Liao, Heng-Sheng Chao, Hwa-Yen Chiu, Ting-Wei Wang, Yen Lee, Jyun-Ru Chen, Tsu-Hui Shiao, Yuh-Min Chen, Yu-Te Wu. A Radiomics-Based Deep Learning Approach to Predict Progression Free-Survival after Tyrosine Kinase Inhibitor Therapy in Nonsmall Cell Lung Cancer. Cancer Imaging 2023; 23(1): 9 (https://doi.org/10.1186/s40644-023-00522-5) ‡ 38. Chuan-Yen Sun, Jhong-Ru Huang, Hisao-Chin Shen, Ying-Ting Liao, Hung-Jui Ko, Chih-Jung Chang, Yuh-Min Chen, Jia-Yih Feng, Wei-Chih Chen, Kuang-Yao Yang. Comparison of clinical outcomes in critically ill COVID-19 patients on mechanical ventilation with nosocomial pneumonia between Alpha and Omicron variants. Therapeutic Advances in Respiratory Disease 2023; 23: 1-11. ‡ 39. Hsiao-Chin Shen, Chun-Chia Chen, Wei-Chih Chen, Wen-Kuang Yu, Kuang-Yao Yang, Yuh-Min Chen. Association of late radiographic assessment of lung edema score with clinical outcome in patients with influenza-associated acute respiratory distress syndrome. Diagnostics 2023; 13: 3572, https://doi.org/10.3390/diagnostics13233572. ‡ 40. Batel Blechter, Li-Hsin Chien, Tzu-Yu Chen, I-Shou Chang, Parichoy Pal Choudhury, Chin-Fu Hsiao, Xiao-Ou Shu, Jason Y. Y. Wong, Kuan-Yu Chen, Gee-Chen Chang, Ying-Huang Tsai, Wu-Chou Su, Ming-Shyan Huang, Yuh-Min Chen, Chih-Yi Chen, Hsiao-Han Hung, Jia-Wei Hu, Jianxin Shi, Wei Zheng, Anne F. Rositch, Chien-Jen Chen, Nilanjan Chatterjee, Pan-Chyr Yang, Nathaniel Rothman, Chao Agnes Hsiung, Qing Lan. Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in Taiwan. JAMA Network Open 2023; 6 (11): e2339254. ‡ 41. Ting Wei Wang, Heng-Sheng Chao, Hwa-Yen Chiu, Chia-Feng Lu, Chien-Yi Liao, Yen Lee, Jyun-Ru Chen, Tsu-Hui Shiao, Yuh-Min Chen, Yu-Te Wu. Radiomics of Metastatic Brain Tumor as a Predictive Image Biomarker of ProgressionFree Survival in Patients with Non-Small-Cell Lung Cancer with Brain Metastasis Receiving Tyrosine Kinase Inhibitors. Translational Oncology 2024 Jan; 39: 101826. ‡ 42. Kung-Hao Liang, Yung-Hung Luo, Mong-Lien Wang, Shih-Hwa Chiou, Yuh-Min Chen, Han-Shui Hsu. A multi-omic investigation of lung adenocarcinoma molecular subtypes. J Chinese Medical Association 2024; 87(1): 33-39. *‡ 43. Chia-I Shen, Chi-Lu Chiang, Hsu-Ching Huang, Yen-Han Tsen, Yung-Hung Luo, Huai-Che Yang, Yuh-Min Chen. Management strategies for intracranial progression in ALK-positive non-small cell lung cancer: a real-world cohort study. Journal of Neuro-Oncology 2023; 165: 459-465. ‡ 44. Ting-Wei Wang, Heng-Sheng Chao, Hwa-Yen Chiu, Yi-Hui Lin, Hung-Chun Chen, Chia-Feng Lu, Chien-Yi Liao, Yen Lee, Tsu-Hui Shiao, Yuh-Min Chen, Jing-Wen Huang, Yu-Te Wu. Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients. Cancers 2023; 15: 5125. ‡ 45. Wang C-L, Hsu K-H, Chang Y-H, Ho C-C, Chiang C-J, Chen K-C, Cheung YC, Huang P-C, Chen Y-R, Chen C-Y, Hsu C-P, Hsia J-Y, Chen H-Y, Yang S-Y, Li Y-J, Yang T-Y, Tseng J-S, Chuang C-Y, Hsiung CA, Chen Y-M, Huang M-S, Yu C-J, Chen K-Y, Su W-C, Chen JJW, Yu S-L, Chen C-J, Yang P-C, Tsai Y-H, Chang G-C, Low-dose CT screening in relatives with a family history of lung cancer. Journal of Thoracic Oncology 2023; 18: 1492-1503. *‡ 46. Ting Wei Wang, Ming-Sheng Hsu, Yi-Hui Lin, Hwa-Yen Chiu, Heng-Sheng Chao, Chien-Yi Liao, Chia-Feng Lu, Yu-Te Wu, Jing-Wen Huang, Yuh-Min Chen. Application of Radiomics in Prognosing Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Systematic review and Meta-Analysis. Cancers (Basel) 2023 Jul 8;15(14):3542. ‡ 47. Ying-Ting Liao, Lei-Chi Wang, Ruei-Lin Sun, Yi-Chen Yeh, Hsu-Ching Huang, Chia-I Shen, Yen-Han Tseng, Tsu-Hui Hsiao, Heng-Sheng Chao, Yung-Hung Luo, Yuh-Min Chen, Chi-Lu Chiang. Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions. Journal of Cancer Research and Clinical Oncology 2023;149(12):10365-10376. ‡ 48. Jianxin Shi, Kouya Shiraishi, Jiyeon Choi, Keitaro Matsuo, Tzu-Yu Chen, Juncheng Dai, Rayjean J Hung, Kexin Chen, Xiao-Ou Shu, Young Tae Kim, Maria Teresa Landi, Dongxin Lin, Wei Zheng, Zhihua Yin, Baosen Zhou, Bao Song, Jiu-Cun Wang, Wei Jie Seow, Lei Song, I-Shou Chang, Wei Hu, Qiuyin Cai, Yun-Chul Hong, Hee Nam Kim, Yi-Long Wu, Maria Pik Wong, Brian Douglas Richardson, Karen M Funderburk, Shilan Li, Tongwu Zhang, Charles Breeze, Zhaoming Wang, Batel Blechter, Bryan A Bassig, Jin Hee Kim, Demetrius Albanes, Jason Wong, Min-Ho Shin, Lap Ping Chung, Yang Yang, She-Juan An, Hong Zheng, Yasushi Yatabe, Xu-Chao Zhang, Young-Chul Kim, Neil E Caporaso, Jiang Chang, James Chung Man Ho, Michiaki Kubo, Yataro Daigo, Minsun Song, Yukihide Momozawa, Yoichiro Kamatani, Masashi Kobayashi, Kenichi Ohkubo, Takayuki Honda, H Dean III Hosgood, Hideo Kunitoh, Harsh Patel, Shun-ichi Watanabe, Yohei Miyagi, Haruhiko Nakayama, Shingo Matsumoto, Hidehito Horinouchi, Masahiro Tsuboi, Ryuji Hamamoto, Koichi Goto, Yuichiro Ohe, Atsushi Takahashi, Akiteru Goto, Yoshihiro Minamiya, Megumi Hara, Yuichiro Nishida, Kenji Takeuchi, Kenji Wakai, Koichi Matsuda, Yoshinori Murakami, Kimihiro Shimizu, Hiroyuki Suzuki, Motonobu Saito, Yoichi Ohtaki, Kazumi Tanaka, Tangchun Wu, Fusheng Wei, Hongji Dai, Mitchell John Machiela, Jian Su, Yeul Hong Kim, In-Jae Oh, Victor Ho Fun Lee, Wu-Chou Su, Yuh-Min Chen, Gee-Chen Chang, Kuan-Yu Chen, …. Identification of multiple variants in a genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nature Communications 2023; 14: 3043. ‡ 49. Chi-Lu Chiang, Hsiang-Ling Ho, Yi-Chen Yeh, Cheng-Chia Lee, Hsu-Ching Huang, Chia-I Shen, Yung-Hung Luo, Yuh-Min Chen, Chao-Hua Chiu, Teh-Ying Chou. Efficacy of Different Platforms in Detecting EGFR Mutations Using Cerebrospinal Fluid Cell-Free DNA from Non-Small Cell Lung Cancer Patients with Leptomeningeal Metastases. Thoracic Cancer 2023 Mar 28. doi: 10.1111/1759-7714.14866 ‡ 50. Parneet Cheema, Byoung Chul Cho, Helano Freitas, Mariano Provencio, Yuh-Min Chen, Sang-We Kim, Yi-Long Wu, Antonio Passaro, Claudio Martin, Marcello Tiseo, Gee-Chen Chang, Keunchil Park, Benjamin Solomon, Otto Burghuber, MD, Janessa Laskin, Ziping Wang, Sung Yong Lee, Yanping Hu, Johan Vansteenkiste, He-Long Zhang, Emer Hanrahan, Thomas Geldart, Rosemary Taylor, Leslie Servidio, Jingyi Li, Filippo de Marinis. A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data. Future Oncology 2023; 19: https://doi.org/10.2217/fon-2022-0919 ‡ 51. Yuan-Hung Wu, Yu-Mei Kang, Yu-Wen Hu, Keng-Li Lan, Sang-Hue Yen, Tzu-Yu Lai, Tien-Li Lan, Yuh-Min Chen, Chao-Hua Chiu, Yung-Hung Luo, Heng-Sheng Chao, Chi-Lu Chiang, Tsu-Hui Shiao, Chao-Neng Yang, Wen-Hu Hsu, Yu-Chung Wu, Han-Shui Hsu, Jung-Jyh Hung, Chien-Sheng Huang, Po-Kuei Hsu, Yi-Wei Chen. Old age and EGFR mutation status in inoperable early-stage non-small cell lung cancer receiving stereotactic ablative radiotherapy: a single institute experience of 71 patients in Taiwan. Thorac Cancer. 2023;14:654–661. ‡ 52. Kumar Prabhash, Daniel Shao Weng Tan, Ross A. Soo, Piyada Sitthideatphaiboon, Yuh Min Chen, Pei Jye Voon, Elisna Syahruddin, Sojung Chu, Reto Huggenberger, Byoung-Chul Cho. Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset. Frontiers in Oncology 2023; 13:1117348. ‡ 53. Chia-Feng Lu; Chien-Yi Liao; Heng-Sheng Chao; Hwa-Yen Chiu; Ting-Wei Wang; Yen Lee; Jyun-Ru Chen; Tsu-Hui Shiao; Yuh-Min Chen; Yu-Te Wu. A Radiomics-Based Deep Learning Approach to Predict Progression Free-Survival after Tyrosine Kinase Inhibitor Therapy in Non-small Cell Lung Cancer. Cancer Imaging 2023 Jan 20;23(1):9. doi: 10.1186/s40644-023-00522-5. *‡ 54. Heng-Sheng Chao, Chiao-Yun Tsai, Chung-Wei Chou, Tsu-Hui Shiao, Hsu-Chih Huang, Kun-Chieh Chen, Hao-Hung Tsai, Chin-Yu Lin, Yuh-Min Chen. Artificial intelligence assisted computational tomographic detection of lung nodules for prognostic cancer examination: a large-scale clinical trial. Biomedicines 2023; 11(1) Jan: 147. doi: 10.3390/biomedicines11010147 ‡ 55. Hwa-Yen Chiu, Kun-Ta Chou, Kang-Cheng Su, Fang-Chi Lin, Yung-Yang Liu, Tsu-Hui Shiao, Yuh-Min Chen. Obstructive Sleep Apnea in Young Asian Adults. Scientific Reports 2022; 12: 20582. ‡ 56. Sheng-Wei Pan, Rehan R. Syed, Donald G. Catanzaro, Mei-Lin Ho, Chin-Chung Shu, Tsung-Yeh Tsai, Yen-Han Tseng, Jia-Yih Feng, Yuh-Min Chen, Wei-Juin Su, Antonino Catanzaro, Timothy C. Rodwell. Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of disease. Frontiers in Immunology 2022; 13:1040947. ‡ 57. Hwa-Yen Chiu, Rita Huan-Ting Peng, Yi-Chian Lin, Ting-Wei Wang, Ya-Xuan Yang, Ying-Ying Chen, Mei-Han Wu, Tsu-Hui Shiao, Heng-Shen Chao, Yuh-Min Chen, Yu-Te Wu. Artificial intelligence for early detection of chest nodules in X-ray images. Biomedicines 2022, 10, 2839. https://doi.org/10.3390/biomedicines10112839 ‡ 58. Chuan Yen Sun, Jia-Yih Feng, Jhong-Ru Huang, Hisao-Chin Shen, Yuh-Min Chen, Wei-Chih Chen, Kuang-Yao Yang. Clinical outcomes and prolonged SARS-CoV-2 viral shedding in ICU patients with severe COVID-19 infection and nosocomial bacterial pneumonia: a retrospective cohort study. Journal of Clinical Medicine 2022, 11 (22), 6796. *‡ 59. Heng-Sheng Chao, Yu-Hong Wu, Linda Siana, Yuh-Min Chen. Generating High-Resolution CT Slices from Two Image Series Using Deep Learning-Based Resolution Enhancement Methods. Diagnostics 2022 Nov 8;12(11):2725. doi: 10.3390/diagnostics12112725. ‡ 60. Chi-Lu Chiang, Huai-Che Yang, Yung-Hung Luo, Ching-Jen Chen, Hsiu-Mei Wu, Yuh-Min Chen, Yong-Sin Hu, Chung-Jung Lin, Wen-Yuh Chung, Cheng-Ying Shiau, Wan-Yuo Guo, Teh-Ying Chou, David Hung-Chi Pan, Cheng-Chia Lee. Leptomeningeal Metastasis in Patients with Non-Small Cell Lung Cancer after Stereotactic Radiosurgery for Brain Metastasis. Journal of Neurosurgery 2022 Dec 9;139(2):385-392. ‡ 61. Sheng-Wei Pan, Jia-Yih Feng, Lawrence Shih-Hsin Wu, Chin-Chung Shu, Pin-Huai Wang, Jann-Yuan Wang, Hao-Chien Wang, Wei-Juin Su, Yuh-Min Chen, Chong-Jen Yu. Sex‑specific associations between susceptibility to Mycobacterium avium complex-lung disease and PDCD-1 gene polymorphisms. Journal of Infectious Diseases 2022 Aug 25;75(2):239-247. ‡ 62. Li-Hsin Chien, Tzu-Yu Chen, Chung-Hsing Chen, Kuan-Yu Chen, Chin-Fu Hsiao, Gee-Chen Chang, Ying-Huang Tsai, Wu-Chou Su, Ming-Shyan Huang, Yuh-Min Chen, Chih-Yi Chen, Sheng-Kai Liang, Chung-Yu Chen, Chih-Liang Wang, Hsiao-Han Hung, Hsin-Fang Jiang, Jia-Wei Hu, Nathaniel Rothman, Qing Lan, Tsang-Wu Liu, Chien-Jen Chen, Pan-Chyr Yang, I-Shou Chang, Chao A. Hsiung. Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan. Cancer Epidemiology Biomarkers & Prevention 2022 Dec 5;31(12):2208-2218. ‡ 63. Hwa-Yen Chiu, Yung-Yang Liu, Tsu-Hui Shiao, Kang-Cheng Su, Kun-Ta Chou, Yuh-Min Chen. Clinical Characteristics of Rapid Eye Movement-related Obstructive Sleep Apnea: An experience in a Tertiary Medical Center of Taiwan. Nature and Science of Sleep 2022:14 1521–1532. ‡ 64. Jhong-Ru Huang, Hisao-Chin Shen, Chuan-Yen Sun, Wei-Chih Chen, Yuh-Min Chen, Jia-Yih Feng, Kuang-Yao Yang. COVID-19-associated pulmonary aspergillosis is associated with higher in-hospital mortality and prolonged viral shedding of SARS-CoV-2. Journal of the Formosan Medical Association 2022 Dec;121(12):2617-2625. *‡ 65. Yung-Hung Luo, Kung-Hao Liang, Chi-Lu Chiang, Chia-I Shen, Hsu-Ching Huang, Mong-Lien Wang, Shih-Hwa Chiou, Yuh-Min Chen. State-of-the-Art Molecular Oncology of lung cancer in Taiwan. International Journal of Molecular Sciences 2022, 23, 7037. https://doi.org/10.3390/ijms23137037 ‡ 66. Ruei-Lin Sun, Sheng-Wei Pan, Jia-Yih Feng, Chun-Yu Liu, Yuh-Min Chen. Osteoblastic flare phenomenon in a patient treated for disseminated nontuberculous mycobacterial infection. Thorax 2022; Nov;77(11):1152-1153. ‡ 67. Vincent Yi-Fong Su, Kun-Ta Chou, Chun-Hsien Tseng, Chia-Yu Kuo, Kang-Cheng Su, Diahn-Warng Perng, Yuh-Min Chen, Shi-Chuan Chang. Mouth opening/breathing is common in sleep apnea and linked to more nocturnal water loss. Biomedical Journal 2022 May 9; S2319-4170(22)00073-7. doi: 10.1016/j.bj.2022.05.001. Online ahead of print. ‡ 68. Hwa-Yen Chiu, Heng-Sheng Chao, Yuh-Min Chen. Application of artificial intelligence in lung cancer. Cancers (Basel) 2022 Mar 8;14(6):1370. doi: 10.3390/cancers14061370. ‡ 69. Chao-Yu Liu, Heng-Fu Lin, Wei-Yi Lai, Yi-Ying Lin, Tzu-Wei Lin, Yi-Ping Yang, Fu-Ting Tsai, Chia-Lin Wang, Yung-Hung Luo, Yuh-Min Chen, Po-Kuei Hsu, Loh Jit Kai, Alan Ong Han Kiat, Yueh Chien, Shih-Hwa Chiou, Chien-Ying Wang. Molecular target therapeutics of EGF-TKI and wosnstream signaling pathways in non-small cell lung cancers. J Cinese Medical Association 2022; 94 April: 409-413. ‡ 70. Yi-Luen Shen, Chia-I Shen, Chi-Lu Chiang, Hsu-Ching Huang, Kun-Ta Chou, Chao-Hua Chiu, Yuh-Min Chen, Yung-Hung Luo. Reduced FEV1 as prognostic factors in patients with advanced NSCLC receiving immune checkpoint inhibitors. Frontiers in Medicine 2022; 23 (March): 1619 https://doi.org/10.3389/fmed.2022.860733. ‡ 71. Sheng-Wei Pan, Chin-Chung Shu, Jhong-Ru Huang, Chang-Ching Lee, Yen-Han Tseng, Jung-Jyh Hung, Po-Kuei Hsu, Nien-Jung Chen, Wei-Juin Su, Jia-Yih Feng, Yuh-Min Chen. PD-L1 expression in monocytes correlates with bacterial burden and treatment outcomes in active pulmonary tuberculosis. International Journal of Molecular Sciences 2022, 23, 1619. https://doi.org/10.3390/ijms23031619. *‡ 72. Chi-Lu Chiang, Ping-Chung Tsai, Yi-Chen Yeh, Yuan-Hung Wu, Han-Shui Hsu, Yuh-Min Chen. Recent advances in the Diagnosis and Management of Multiple Primary Lung Cancer. Cancers 2022, 14, 242 https://doi.org/10.3390/cancers14010242. ‡ 73. Yung-Hung Luo, Yi-Ping Yang, Chian-Shiu Chien, Aliaksandr A. Yarmishyn, Afeez Ishola, Yueh Chien, Yuh-Min Chen, Ping-Hsing Tsai, Tzu-Wei Lin, Mong-Lien Wang, Shih-Hwa Chiou. Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-small Cell Lung Cancer. International Journal of Molecular Sciences 2022, 23, 64. https://doi.org/10.3390/ ijms23010064. ‡ 74. Sheng-Wei Pan, Wei-Juin Su, Yu-Jiun Chan, Mei-Lin Ho, Jia-Yih Feng, Chin-Chung Shu, Jann-Yuan Wang, Hao-Chien Wang, Chong-Jen Yu, Yuh-Min Chen. Disease progression in patients with nontuberculous mycobacterial lung disease of nodular bronchiectatic (NB) pattern: the role of cavitary NB and soluble programmed death protein-1. Clinical Infectious Diseases 2022 Aug 25;75(2):239-247 ‡ 75. Xiuning Le, Hiroshi Sakai, Enriqueta Felip, Remi Veillon, Marina Chiara Garassino, Jo Raskin, Alexis B. Cortot, Santiago Viteri, Julien Mazieres, Egbert Smit, Michael Thomas, Byoung Chul Cho, James Chih-Hsin Yang, Yuh-Min Chen, Jyoti Patel, Keunchil Park, Frank Griesinger, Melissa Johnson, Maya Gottfried, Christian Britschgi, John Heymach, Karl-Maria Schumacher, Rolf Bruns, Karin Berghoff, Gordon Otto, Paul K. Paik. Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from VISION with Relevance for Clinical Practice. Clinical Cancer Research 2022 Mar 15;28(6):1117-1126. ‡ 76. Afeez Ishola, Chian-Shiu Chien, Yi-Ping Yang, Yueh Chien, Aliaksandr Yarmishyn, Ping-Hsing Tsai, Jerry Chen, Po-Kuei Hsu, Yung-Hung Luo, Yuh-Min Chen, Kung-Hao Liang, Yuan-Tzu Lan, Teh-Ia Huo, Hsin-I Ma, Ming-Teh Chen, Mong-Lien Wang, and Shih-Hwa Chiou. Oncogenic circRNA hsa_circ_0000190 modulates EGFR/ERK pathway in promoting NSCLC. Cancer Research 2022 Jan 9; 82(1): 75-89.. ‡ 77. Chih-Jung Chang, Sheng-Wei Pan, Yuh-Min Chen. Chest film demonstrating reverse batwing pulmonary opacities in a patient with COVID-19 pneumonia. Tuberculosis and Respiratory Diseases 2022; 85(1): 96-97. *‡ 78. Hsin-Kuo Ko, Wen-Kuang Yu, Sheng-Wei Pan, Wei-Chih Chen, Kuang-Yao Yang, Yi-Tsung Lin, Fu-Der Wang, Muh-Hwa Yang, Yuh-Min Chen. Consensus statement and recommendations on the treatment of COVID-19: 2021 update. J Chinese Medical Association 2022; 85(Jan): 5-17. ‡ 79. Kun-Ta Chou, Yu-Lun Tsai, Wan-Yu Yeh, Yuh-Min Chen, Nicole Huang, Hao-Min Cheng. Risk of Work-related Injury in Workers with Obstructive Sleep Apnea: A Systematic Review and Meta-analysis. Journal of Sleep Research 2022; 31: e13446. https://doi.org/10.1111/jsr.13446 (2020 IF 3.981) ‡ 80. Yung-Hung Luo, Han Liu, Jason A. Wampfler, Yalun Li, Tobias Peikert, Dan Liu, Konstantinos Leventakos, Yuh-Min Chen, Yanan Yang, Shih-Hwa Chiou, Ping Yang. Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without T790M mutation. Journal of Cancer Research and Clinical Oncology 2021 Aug 26. doi: 10.1007/s00432-021-03766-5. ‡ 81. Enriqueta Felip, Nasser Altorki, Caicun Zhou, Tibor Csőszi, Ihor Vynnychenko, Oleksandr Goloborodko, Alexander Luft, Andrey Akopov, Alex Martinez-Marti, Hirotsugu Kenmotsu, Yuh-Min Chen, Antonio Chella, Shunichi Sugawara, David Voong, Fan Wu, Jing Yi, Yu Deng, Mark McCleland, Elizabeth Bennett, Barbara Gitlitz, Heather Wakelee. Adjuvant Atezolizumab After Chemotherapy in Stage IB-IIIA Non-Small Cell Lung Cancer. Lancet 2021; 398 Oct:1344-57. (2020 IF 79.321) ‡ 82. Jia Yih Feng, Yi Tzu Lee, Sheng Wei Pan, Kuang Yao Yang, Yuh Min Chen, David Hung Tsang Yen, Szu Yuan Li, Fu Der Wang. Comparison of colistin-induced nephrotoxicity between two diferent formulations of colistin in critically ill patients: a retrospective cohort study. Antimicrob Resist Infect Control 2021; 10 (July): 111. https://doi.org/10.1186/s13756-021-00977-w ‡ 83. Sheng-Wei Pan, Sheng-Wei Pan, Wei-Juin Su, Yu-Jiun Chan, Fan-Yi Chuang, Yuh-Min Chen, Jia-Yih Feng. Mycobacterium tuberculosis–derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection. PLOS ONE 2021 Jun 24;16(6):e0253879. doi: 10.1371/journal.pone.0253879. (2020 IF 3.240) ‡ 84. Sheng-Kai Liang, Li-Hsin Chien, Gee-Chen Chang, Ying-Huang Tsai, Wu-Chou Su, Yuh-Min Chen, Ming-Shyan Huang, Hsien-Chih Lin, Wen-Tsen Fang, Hsiao-Han Hung, Shih-Sheng Jiang, Chih-Yi Chen, Kuan-Yu Chen, I-Shou Chang, Chao A Hsiung, Chien-Jen Chen, and Pan-Chyr Yang. Programmed Death Ligand 2 Gene Polymorphisms Are Associated with Lung Adenocarcinoma Risk in Female Never-Smokers. Frontioners in Oncology 2021 Sep 24; 11: 753788 doi: 10.3389/fonc.2021.753788. (2020 IF 6.244) *‡ 85. Chia-I Shen, Heng-Sheng Chao, Tsu-Hui Shiao, Chi-Lu Chiang, Hsu-Ching Huang, Yung-Hung Luo, Chao-Hua Chiu, Yuh-Min Chen. Comparison of the outcome between immunotherapy alone and in combination with chemotherapy in EGFR-mutant non-small cell lung cancer. Scientific Report 2021;11 August: 16122. (2020 IF 4.379) ‡ 86. Pai-Chi Teng, Yanwen Liang, Aliaksandr A. Yarmishyn, Ting-Yi Lin, Tzu-Wei Lin, Yuan-Chi Teng, Yi-PIng Yang, Mong-Lien Wang, Chian-Shiu Chien, Yung-Hung Luo, Yuh-Min Chen, Po-Kuei Hsu, Yu-Jer Hsiao, Shih-Hwa Chiou, Yueh Chien. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases. International Journal of Molecular Sciences 2021; 22: 10592 https://doi.org/10.3390/ijms221910592. *‡ 87. Chi-Lu Chiang, Wen-Ting Hsieh, Chao-Hsiun Tang, Mei-Ling Sheu, Yuh-Min Chen. Treatment patterns and survival in patients with small cell lung cancer in Taiwan. J Chinese Medical Association 2021; 84 August: 772-77. (2020 IF 2.743) ‡ 88. Gee-Chen Chang, David Chi-Leung Lam, Chun-Ming Tsai, Yuh-Min Chen, Jin-Yuan Shih, Shyam Aggarwal, Shuhang Wang, Sang-We Kim, Young-Chul Kim, Ibrahim Wahid, Rubi Li, Darren Wan-Teck Lim, Virote Sriuranpong, Raymond Tsz-Tong Chan, Robert M Lorence, Philippe Carriere, Christina Raabe, Agnieszka Cseh, Keunchil Park. Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations. International Journal of Clinical Oncology 2021May; 26(5): 841-850. (2020 IF 3.402) ‡ 89. Sheng-Wei Pan, Chin-Chung Shu, Chang-Ching Lee, Jia-Yih Feng, Yu-Jiun Chan, Yuh-Min Chen, Wei-Juin Su. Role of Soluble T-Cell Immunoglobulin Mucin Domain-3 in Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Colonization. Archivos De Bronconeumologia 2021 accepted. (2020IF 4.872) ‡ 90. Cheng-Hsuan Liu, Hsuan-Yang Huang, Yung-Fang Tu, Wei-Yi Lai, Chia-Lin Wang, Jun-Ren Sun, Yueh Chien, Tzu-Wei Lin, Yi-Ying Lin, Chian-Shiu Chien, Chih-Heng Huang, Yuh-Min Chen, Pin-I Huang, Fu-Der Wang, Yi-Ping Yang. Highlight of SARS-CoV-2 Vaccine Development against COVID-19 Pandemic. Journal of the Chinese Medical Association. 2021; Jan; 84(1):9-13. (2020 IF 2.743) ‡ 91. Cheng-Hsuan Liu, Hsuan-Yang Huang, Yung-Fang Tu, Wei-Yi Lai, Chia-Lin Wang, Jun-Ren Sun, Yueh Chien, Tzu-Wei Lin, Yi-Ying Lin, Chian-Shiu Chien, Chih-Heng Huang, Yuh-Min Chen, Pin-I Huang, Fu-Der Wang, Yi-Ping Yang. Highlight of severe acute respiratory syndrome coronavirus-2 vaccine development against COVID-19 pandemic. J Chinese Medical Association 2021; 84 (Jan): 9-13 (2020 IF 2.743) *‡ 92. Yung-Hung Luo, Chao-Hua Chiu, Chih-Hsi Scott Kuo, Teh-Ying Chou, Yi-Chen Yeh, Han-Shui Hsu, Sang-Hue Yen, Yuan-Hung Wu, James Chih-Hsin Yang, Bin-Chi Liao, Te-Chun Hsia, Yuh-Min Chen. Lung Cancer in Taiwan. J Thoracic Oncology 2021; 16 (4) Apr: 519-27. (2020 IF 15.609) ‡ 93. Chi-Lu Chiang, Cheng-Chia Lee, Hsu-Ching Huang, Yi-Chen Yeh, Chia-I Shen, Yung-Hung Luo, Tsu-Hui Shiao, Han Jhih Chang, Yu-Ting Huang, Yuh-Min Chen, Teh-Ying Chou, Chao-Hua Chiu. Utility of cerebrospinal fluid cell-free DNA in patients with EGFR mutant non-small cell lung cancer with leptomeningeal metastasis. Targeted Oncology 2021 Feb (published on line:16. 10.1007/s11523-021-00791-9) (2020 IF 4.493) *‡ 94. Vincent Yi Fong Su, Kuang-Yao Yang, Ting Yu Huang, Chia Chen Hsu, Yuh-Min Chen, Jiin Cherng Yen, Yueh Ching Chou, Yuh Lih Chang, Chien Hui He. The efficacy of first line tyrosine kinase inhibitors combined with co medications in Asian patients with EGFR mutation non small cell lung cancer. Scientific Reports 2020; 10(1) Sep 11:14965. (2020 IF 4.379). *‡ 95. Yung-Hung Luo, Hwa-Yen Chiu, Chia-Sui Weng, Aliaksandr A. Yarmishyn, Yuh-Min Chen. Overview of Coronavirus Disease 2019 (COVID-19): Updates and Advances of the treatment. J Chinese Medical Association 2020; 83 (9): 805-8. (2020 IF 2.743) *‡ 96. Hsiao Yi-Han, Lin Yi-Tsung, Liao Hsien-Tzung, Yang Kuang-Yao, Chen Yuh-Min. Using lung ultrasound changes to evaluate the response of recruitment maneuver in a patient recovering from coronavirus disease 2019 with acute respiratory distress syndrome. J Chinese Medical Association 2020; 83(12) Dec: 1117-20. (2020 IF 2.743) ‡ 97. Pin-Hsing Tsai, Wei-Yi Lai, Yi-Ying Lin, Yung-Hung Luo, Yi-Tsung Lin, Hsiao-Kang Chen, Yuh-Min Chen, Yi-Chun Lai, Li-Chiao Kuo, Shew-Dan Chen, Mong-Lien Wang, Shih-Chieh Chang, Fu-Der Wang, Yi-Ping Yang. Clinical manifestation and disease progression in COVID-19 infection. J Chinese Medical Association 2021; 84 (Jan): 3-8 (2020 IF 2.743) *‡ 98. Po-Liang Chen, Yi-Han Hsiao, Chien Chuang, Jia-Yih Feng, Hsiang-Ling Ho, Yi-Tsung Lin, Su-Jung Chen, Shiang-Fen Huang, Hsin-Pai Chen, The-Ying Chou, Yuh-Min Chen, Fu-Der Wang. The clinical manifestations and interval changes of reverse-transcriptase quantitative polymerase chain reactions among different specimens of Coronovirus disease 2019 patients. J Chinese Medical Association 2021; 84 (Feb): 151-57 (2020 IF 2.743) 99. 李彥融、蘇剛正、陳育民. 胸腔病例(三七O) 支氣管囊腫. 臨床醫學 2020; 86(Sept): 576-79. ‡ 100. Vincent Yi Fong Su, Yung-Feng Yen, Kuang-Yao Yang, Wei-Juin Su, Kun-Ta Chou, Yuh-Min Chen, Diahn-Warng Perng. Masks and Me¬dical Care: Two Keys to Taiwan's Success in Preventing COVID¬-19 Spread. Travel Medicine and Infectious Disease 2020 (in print, available on line 4 June 2020, 101780) (2020 IF 6.211). ‡ 101. Chi-Lu Chiang, Hsu-Ching Huang, Chia-I Shen, Yung-Hung Luo, Yuh-Min Chen, Chao-Hua Chiu. Post-progression survival in secondary EGFR T790M-mutated non-small-cell lung cancer patients with and without osimertinib after failure of a previous EGFR TKI. Targeted Oncology 2020 Aug; 15(4): 503-12. (2020 IF 4.493). ‡ 102. Batel Blechtera, Jason YY Wong, Chao Agnes Hsiung, H Dean Hosgood, Zhihua Yin, Xiao-Ou Shu, Han Zhang, Jianxin Shi, Lei Song, Minsun Song, Wei Zheng, Zhaoming Wang, Neil Caporaso, Laurie Burdetteb, Meredith Yeager, Sonja I Berndt, Maria Teresa Landi, Chien-Jen Chen, Gee-Chen Chang, Chin-Fu Hsiao, Ying-Huang Tsai, Kuan-Yu Chen, Ming-Shyan Huang, Wu-Chou Su, Yuh-Min Chen, et al. Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia. Environment International 2021 Feb;147: 105975. (2020 IF 9.621). ‡ 103. Vincent Yi-Fong Su, Sheng-Wei Pan ,Yung-Feng Yen, Jia-Yih Feng, Wei-Juin Su, Yuh-Min Chen. Statin use and impact on tuberculosis risk. Expert Review of Anti-infective Therapy Published online: 01 Mar 2021. (2020 IF 5.091) ‡ 104. Yung-Hung Luo, Yi-Ping Yang, Chian-Shiu Chien, Aliaksandr A. Yarmishyn, Afeez Ishola, Yueh Chien, Yuh-Min Chen, Tsai-Wang Huang, Kang-Yun Lee, Wen-Chien Huang, Ping-Hsing Tsai, Tzu-Wei Lin, Shih-Hwa Chiou, Chao-Yu Liu, Cheng-Chang Chang, Ming-Teh Chen, Mong-Lien Wang. Plasma Level of Circular RNA hsa_circ_0000190 Correlates with Tumor Progression and Poor Treatment Response in Advanced Lung Cancers. Cancers 2020; 12(7): 1740 (2020 IF 6.639). *‡ 105. Hsiu-Ying Hung, Yen-Han Tseng, Heng-Sheng Chao, Chao-Hua Chiu, Wen-Hu Hsu, Han-Shui Hsu, Yu-Chung Wu, Teh-Ying Chou, Chun-Ku Chen, Keng-Li Lan, Yi-Wei Chen, Yuan-Hung Wu, Yuh-Min Chen. Multidisciplinary team discussion results in survival benefit for patients with stage III nonsmall-cell lung cancer. PLOS One 2020; 15 (10) October: e0236503. (2020 IF 3.240). ‡ 106. Paik PK, Felip E, Veillon R, Sakai H, Cortot AB, Garassino MC, Mazieres J, Viteri S, Senellart H, Van Meerbeeck J, Raskin J, Reinmuth N, Conte P, Kowalski D, Cho BC, Patel JD, Horn L, Griesinger F, Han JY, Kim YC, Chang GC, Tsai CL, Yang JCH, Chen YM, Smit E, van der Wekken A, Kato T, Juraeva D, Stroh C, Bruns R, Straub J, Johne A, Scheele J, Heymach JV, Le X. Tepotinib In Patients With MET Exon 14 Skipping Non-Small-Cell Lung Cancer. New Engl J Med 2020; 383 (Sept): 931-43. (2020 IF 91.245). ‡ Yi-Long Wu, Ying Cheng, Jianying Zhou, Shun Lu, Yiping Zhang, Jun Zhao, Dong-Wan Kim, Ross Andrew Soo, Sang-We Kim, Hongming Pan, Yuh-Min Chen, Chih-Feng Chian, Xiaoqing Liu, Daniel Shao Weng Tan, Rolf Bruns, Josef Straub, Andreas Johne, Jurgen Scheele, Keunchil Park, James Chih-Hsin Yang for the INSIGHT Investigators. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial. Lancet Respiratory Medicine 2020; 8(11) Nov: 1132-43. (2020 IF 30.700) *‡ 107. Yuh-Min Chen. First line combination immunotherapy for metastatic non-small-cell lung cancer. Journal Chinese Medical Association-Taipei 2020; 83 (May): 433-441. (2020 IF 2.743) ‡ 108. Li-Hsin Chien, Chung-Hsing Chen, Tzu-Yu Chen, Gee-Chen Chang, Ying-Huang Tsai, Chin-Fu Hsiao, Kuan-Yu Chen, Wu-Chou Su, Wen-Chang Wang, Ming-Shyan Huang, Yuh-Min Chen, Chih-Yi Chen, Sheng-Kai Liang, Chung-Yu Chen, Chih-Liang Wang, Mei-Hsuan Lee, Ren-Hua Chung, Fang-Yu Tsai, Jia-Wei Hu, Hormuzd A. Katki, Nilanjan Chatterjee, Stephen J. Chanock, Nathaniel Rothman, Qing Lan, Pan-Chyr Yang, Chien-Jen Chen, I-Shou Chang, and Chao Agnes Hsiung. Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model. Cancer Epidemiology, Biomarkers & Prevention 2020; 29 (Feb): 452-9 (2020 IF 4.254). ‡ 109. Tzu-Yu Chen, Yao-Hwei Fang, Hui-Ling Chen, Chin-Hao Chang, Hsin Huang, Yi-Song Chen, Kuo-Meng Liao, Hsiao-Yu Wu, Gee-Chen Chang, Ying-Huang Tsai, Chih-Liang Wang, Yuh-Min Chen, Ming-Shyan Huang, Wu-Chou Su, Pan-Chyr Yang, Chien-Jen Chen, Chin-Fu Hsiao, Chao A. Hsiung. Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese women. Scientific Reports 2020; 10: 6774 https://doi.org/10.1038/s41598-020-63656-7 (2020 IF 4.379). *‡ 110. Chien-Hui He, Jen-Fu Shih, Shinn-Liang Lai, Yuh-Min Chen. Non-small lung cancer in the very young: Higher EGFR/ALK mutation proportion than the elder. Journal of Chinese Medical Association. 2020; 83 (May): 461-65. (2020 IF 2.743) *‡ 111. Yuh-Min Chen, James Chih-Hsin Yang, Wu-Chou Su, Inn-Wen Chong, Te-Chun Hsai, Meng-Chih Lin, Gee-Chen Chang, Chao-Hua Chiu, Chao-Chi Ho, Shang-Yin Wu, Jen-Yu Hung, Chin-Chou Wang, Tsung-Ying Yang, Chong-Jen Yu. Safety and efficacy of nivolumab in Taiwanese patients with advanced non-small cell lung cancer ineligible for radical radiotherapy and resistant to a platinum-based chemotherapeutic regimen: a phase II study. Journal of Formosa Association 2020; 119(12) Dec: 1817-26 (2020 IF:3.282) *‡ 112. Chun-Liang Lai, Yu-Fen Wei, Te-Chun Hsia, Gee-Chen Chang, Jiun-Ting Wu, Jung-Yueh Chen, Yuh-Min Chen. First-line Treatment of S-1 plus Cisplatin in Patients with Advanced Non-small-cell Lung Cancer in Taiwan. Asia-Pacific J Clinical Oncology 2020; 16: e68-e73. (2020 IF: 2.601) ‡ 113. Jason Wong, Adeline Seow, Akiteru Goto,…… Yuh-Min Chen, ….et al. Tuberculosis Infection and Lung Adenocarcinoma: Mendelian Randomization and Pathway Analysis of Genome-wide Association Study Data from Never-Smoking Asian Women. Genomics 2020; 112 (March): 1223-32. (2020 IF: 5.736).